×

SaMD

apple-watch-3-2

Not so fast. What really happened with FDA’s clearance of the Apple Watch ECG

By Arthur Brandwood | 10.11.2018
There’s lots of noise about the very rapid de novo clearances for Apple’s “Irregular Rhythm Notification Feature” (DEN 180042) and ECG App (DEN180044) for the Apple Watch. FDA cleared both...
Watch

Software as Medical Devices (SaMD) Growing Regulatory Trends and Opportunities for Innovators

By Luis Jimenez | 09.27.2018
With SaMD attracting larger players and devices like the Apple Watch, FDA and regulators globally, are developing frameworks for regulating these more efficiently. On Sept 11th, 2018 Apple obtained FDA...

Search

Recent Posts

Cybersecurity – Is Your Device Software Secure?

Aug 13, 2019

Inaugural Course on Molecular Toxicology

Aug 5, 2019

Beyond a business merger, diverse skills come together at Brandwood CKC

Aug 5, 2019

Applications Closing Soon – November PL.

Aug 1, 2019

Importance of Innovation

Jul 29, 2019

And so starts the MDR/Brexit fallout… First LRQA and now QS Zurich fall by the wayside

Jun 27, 2019

Categories

Categories

Archives

Archives

Archives

Tags

3D 3D printing 510(k) 510(k) PMA adverse events Apple Watch Artificial Intelligence Australia Biocompatibility Biomechanics Brexit CE CE Certificates CFDA China clinical evidence de novo distribution Europe FDA Health Canada IVD IVDR MDR MDSAP mechanical properties medical device medical devices New Zealand Notified Bodies PMA PMDA postmarket post market premarket Quality Systems Reform regulatory Reimbursement SaMD Software standards Sterilisation TGA Webinar
Translate »